60925-61-3 | (6R,7R)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$93.00	$65.00
250mg	95%	in stock	$173.00	$121.00
1g	95%	in stock	$446.00	$312.00
5g	95%	in stock	$1,535.00	$1,074.00

Description

• Catalog Number: AG64659
• Chemical Name: (6R,7R)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• CAS Number: 60925-61-3
• Molecular Formula: C20H21N7O6S2
• Molecular Weight: 519.554
• MDL Number: MFCD00210833
• SMILES: NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)CSc1nnnn1CC(=O)O

Computed Properties

• Complexity: 905
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 2
• Heavy Atom Count: 35
• Hydrogen Bond Acceptor Count: 12
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 10
• XLogP3: -3.2

Literature

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Prophylactic antibiotics for burns patients: systematic review and meta-analysis.

  BMJ (Clinical research ed.) 20100101

• Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing.

  Archives of gynecology and obstetrics 20050901

• Primary lymphocutaneous nocardiosis in an immunocompetent patient.

  Annals of clinical microbiology and antimicrobials 20040101

• The pharmacokinetics of the interstitial space in humans.

  BMC clinical pharmacology 20030101

• The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M. tuberculosis.

  Proceedings of the National Science Council, Republic of China. Part B, Life sciences 19950401

• In vitro susceptibilities of Mycobacterium tuberculosis to 10 antimicrobial agents.

  Antimicrobial agents and chemotherapy 19880901

• Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages.

  Tubercle 19880301

• Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

  Drugs 19871001

• Treatment of scleroma with ceforanide.

  Archives of otolaryngology--head & neck surgery 19870401

• Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods.

  Antimicrobial agents and chemotherapy 19850101

• Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.

  Pharmacotherapy 19820101

• Control of phenylalanine hydroxylase synthesis in tissue culture by serum and insulin.

  Journal of cellular physiology 19760101